Model-based approach to the design of pharmaceutical roller-compaction processes.

Design space prediction Roller compaction Solid fraction Throughput

Journal

International journal of pharmaceutics: X
ISSN: 2590-1567
Titre abrégé: Int J Pharm X
Pays: Netherlands
ID NLM: 101753452

Informations de publication

Date de publication:
Dec 2019
Historique:
received: 02 10 2018
revised: 18 12 2018
accepted: 29 12 2018
entrez: 14 9 2019
pubmed: 14 9 2019
medline: 14 9 2019
Statut: epublish

Résumé

This work presents a new model based approach to process design and scale-up within the same equipment of a roller compaction process. The prediction of the operating space is not performed fully in-silico, but uses low-throughput experiments as input. This low-throughput data is utilized in an iterative calibration routine to describe the behavior of the powder in the roller compactor and improves the predictive quality of the mechanistic models at low and high-throughput. The model has been validated with an experimental design of experiments of two ibuprofen formulations. The predicted sweet spots in the operating space are in good agreement with the experimental results.

Identifiants

pubmed: 31517270
doi: 10.1016/j.ijpx.2019.100005
pii: S2590-1567(19)30019-2
pii: 100005
pmc: PMC6733294
doi:

Types de publication

Journal Article

Langues

eng

Pagination

100005

Commentaires et corrections

Type : ErratumIn

Références

Eur J Pharm Biopharm. 2004 Sep;58(2):317-26
pubmed: 15296958
J Pharm Sci. 2005 Jul;94(7):1589-97
pubmed: 15924348
Drug Dev Ind Pharm. 2008 Feb;34(2):142-8
pubmed: 18302032
AAPS PharmSciTech. 2008;9(2):597-604
pubmed: 18459052
Eur J Pharm Biopharm. 2009 Oct;73(2):219-29
pubmed: 19406236
Int J Pharm. 2011 Sep 15;416(1):110-9
pubmed: 21708239
Pharm Dev Technol. 2010 Jun;15(3):223-9
pubmed: 22716462
Int J Pharm. 2012 Oct 15;436(1-2):486-507
pubmed: 22721851
Int J Pharm. 2012 Nov 15;438(1-2):307-26
pubmed: 22982489
J Pharm Sci. 2013 Oct;102(10):3586-95
pubmed: 23934748
J Pharm Sci. 2014 Jul;103(7):2062-2071
pubmed: 24840775
Pharm Dev Technol. 2015 Jan;20(1):12-21
pubmed: 25162770
Int J Pharm. 2015 Apr 30;484(1-2):192-206
pubmed: 25701630
Eur J Pharm Biopharm. 2016 Sep;106:9-14
pubmed: 27063416
Eur J Pharm Biopharm. 2016 Sep;106:38-49
pubmed: 27237776
Int J Pharm. 2016 Aug 20;510(1):285-95
pubmed: 27346416
Drug Dev Ind Pharm. 2018 Aug;44(8):1295-1306
pubmed: 29484952
Int J Pharm. 2018 Aug 25;547(1-2):469-479
pubmed: 29885512

Auteurs

Peter Toson (P)

Research Center Pharmaceutical Engineering GmbH, Inffeldgasse 13, 8010 Graz, Austria.

Diogo G Lopes (DG)

Research Center Pharmaceutical Engineering GmbH, Inffeldgasse 13, 8010 Graz, Austria.

Raphael Paus (R)

Discovery, Product Development and Supply, Pharmaceutical Research and Development, Division of Janssen Pharmaceutica, Johnson & Johnson, Turnhoutseweg 30, B-2340 Beerse, Belgium.

Ashish Kumar (A)

Discovery, Product Development and Supply, Pharmaceutical Research and Development, Division of Janssen Pharmaceutica, Johnson & Johnson, Turnhoutseweg 30, B-2340 Beerse, Belgium.

Jeroen Geens (J)

Discovery, Product Development and Supply, Pharmaceutical Research and Development, Division of Janssen Pharmaceutica, Johnson & Johnson, Turnhoutseweg 30, B-2340 Beerse, Belgium.

Sandy Stibale (S)

Institute of Pharmaceutics and Biopharmaceutics, Heinrich Heine University, Universitätsstraße 1, 40225 Düsseldorf, Germany.

Julian Quodbach (J)

Institute of Pharmaceutics and Biopharmaceutics, Heinrich Heine University, Universitätsstraße 1, 40225 Düsseldorf, Germany.

Peter Kleinebudde (P)

Institute of Pharmaceutics and Biopharmaceutics, Heinrich Heine University, Universitätsstraße 1, 40225 Düsseldorf, Germany.

Wen-Kai Hsiao (WK)

Research Center Pharmaceutical Engineering GmbH, Inffeldgasse 13, 8010 Graz, Austria.

Johannes Khinast (J)

Research Center Pharmaceutical Engineering GmbH, Inffeldgasse 13, 8010 Graz, Austria.
Institute for Process and Particle Engineering, Graz University of Technology, Inffeldgasse 13, 8010 Graz, Austria.

Classifications MeSH